Balance Sheet

Cash Flow Statement

Amortization Amortization Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

BioNTech SE (BNTX) Change in Intangibles (2024 - 2025)

BioNTech SE's Change in Intangibles history spans 2 years, with the latest figure at $1.3 million for Q4 2025.

On a quarterly basis, Change in Intangibles rose 104.89% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$31.6 million, a N/A change, with the full-year FY2025 number at -$648.4 million, down 265.97% from a year prior.
Change in Intangibles hit $1.3 million in Q4 2025 for BioNTech SE, up from -$3.2 million in the prior quarter.
Over the last five years, Change in Intangibles for BNTX hit a ceiling of $1.3 million in Q4 2025 and a floor of -$56.8 million in Q2 2024.